JPRN-UMIN000027846Completed未知
the efficacy of nicorandil in percutaneouns coronary intervention post procedure MI study - PCI post procedure MI study
Tsukazaki Hospital Department of Cardiology0 sites100 target enrollmentStarted: June 21, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18years-old to 100years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Unknown
Phase 4
Efficacy Study of Nicorandil on NeointimaAngina, UnstableDiabetes MellitusNCT02328521Zhang Ying Qian48
Active, not recruiting
Not Applicable
The effect of intracoronary nicorandil in improving coronary blood flow during primary angioplastyCTRI/2018/10/015937Dr Sreejith A G
Unknown
Phase 3
A comparison of anti-anginal effects of nicorandil (SG-75) with isosorbide mononitrate (ISMN) in patients with stable angina pectoris:A multicenter, randomized, double-blind trial in China.Stable angina pectorisJPRN-jRCT2080220014Chugai Pharmaceutical Co., Ltd.
Completed
Phase 4
Clinical Efficacy and SAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary InterventionST Elevation Myocardial InfarctionPercutaneous Coronary InterventionNCT04665648Fudan University1,500
Completed
Phase 2
Efficacy of nicorandil in acute coronary syndromeAcute coronary syndrome.Ischaemic heart disease120_125IRCT201202189067N1Vice chancellor for research, Kermanshah University of Medical Siences and Health Services252